Open Heart Podcast

Health & Wellness Podcasts

Open Heart is an online-only, open access cardiology journal dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Its goal is to ensure maximum transparency and maximum impact on research progress and patient care. The journal is published by BMJ in partnership with the British Cardiovascular Society. Open Heart aims to operate a fast submission and review process with continuous publication online, to ensure timely, up-to-date research is available worldwide. The journal adheres to a rigorous and transparent peer review process, and papers are considered on methodological soundness rather than priority or novelty.

Location:

United Kingdom

Genres:

Health & Wellness Podcasts

Description:

Open Heart is an online-only, open access cardiology journal dedicated to publishing high quality, peer reviewed medical research in all disciplines and therapeutic areas of cardiovascular medicine. Its goal is to ensure maximum transparency and maximum impact on research progress and patient care. The journal is published by BMJ in partnership with the British Cardiovascular Society. Open Heart aims to operate a fast submission and review process with continuous publication online, to ensure timely, up-to-date research is available worldwide. The journal adheres to a rigorous and transparent peer review process, and papers are considered on methodological soundness rather than priority or novelty.

Twitter:

@Open_HeartBMJ

Language:

English

Website:

http://openheart.bmj.com/

Episodes

A balanced omega-6/omega-3 ratio in the Greek Diet: the powerful aid in fighting obesity

10/3/2016

The truths and myths about the relationship between omega-6 and omega-3 intake and prevention of obesity are revealed in this podcast. The Editor in Chief of Open Heart, Pascal Meier, interviews Artemis Simopoulos, the author of an editorial which underlines the importance of finding the balance on the consumption of fatty-acids, by lowering the amount of omega-6 intake and increasing the amount of omega-3. “If we don’t do this, I don’t think we will ever be able to lower the body weight of the population closer to a normal range”, she says. Dr. Artemis Simopoulos, the Founder and President of the Center for Genetics, Nutrition and Health, Washington, DC, advocates that the preferred ratio of omega-6 to omega-3 for optimal health is 1:2/1. Therefore, it is time to replace popular cooking oils such as sunflower or corn oil, by canola, flaxseed or nuts oils, specially in Western countries. With the same balance in mind, “the intake of green leafy vegetables [rich in omega-3 fatty acids] and fruit needs to be considered very seriously”. Read the full article here: http://openheart.bmj.com/content/3/2/e000385.full.

Duration:00:22:15

Why we were wrong about dietary fat guidelines

2/5/2015

Rahul Bahl, Open Heart associate editor, talks to Zoe Harcombe about her article: Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: A systematic review and meta-analysis.

Duration:00:15:49

CDIS 2014: Tackling global reimbursement considerations: How does this impact trial design?

2/3/2014

By Perry Bridger. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:31:05

CDIS 2014: Commissioning through evaluation, and streamlining the commissioning process

2/3/2014

By Wayne Bartlett-Syree and Mark de Belder. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:27:59

CDIS 2014: New technology appraisal and commissioning discussion

2/3/2014

This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:17:23

CDIS 2014: Summit summary and closing comments

2/3/2014

With John Martin. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:06:34

CDIS 2014: Inside NICE: Defining cost effectiveness and technology assessment

2/3/2014

By Mirella Marlow. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:22:45

CDIS 2014: Funding opportunities from the British Heart Foundation

2/3/2014

By Peter Weissberg, medical director, British Heart Foundation. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:14:40

CDIS 2014: NIH initiatives - early stage funding opportunities for device innovation

2/3/2014

By Jodi Black, deputy director, Office of Translational Alliances and Coordination, NIH. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:24:38

CDIS 2014: Innovation: Preclinical and imaging in device iteration discussion

1/30/2014

Duration:00:30:14

CDIS 2014: Preclinical evaluation case examples: How pathologists can streamline device development

1/30/2014

By Michael Joner. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:17:46

CDIS 2014: Neurodeflection for TAVI: Establishing clinical need and approval pathway

1/30/2014

By Pauliina Margolis, Keystone Heart. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:29:04

CDIS 2014: Intellectual property disasters I have lived through and you should avoid

1/30/2014

By Maurice Buchbinder. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:23:06

CDIS 2014: Implementing EMA guidelines for DES CE approval

1/30/2014

With Bart Segers and Christine Shan. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:18:43

CDIS 2014: Can regulators facilitate innovation while balancing responsibilities for patient safety?

1/30/2014

By Ian Hudson, chief executive Medicines and Healthcare Product Regulatory Agency. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:33:10

CDIS 2014: British healthcare policy and funding for MedTech discussion

1/30/2014

Duration:00:28:37

CDIS 2014: Targeted biologics: The future of medicine, innovation, and interventional therapeutics

1/30/2014

By John Martin. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:22:19

CDIS 2014: Can the UK gain a competitive edge in BioTech? Role, goals, and challenges of NOCRI

1/30/2014

By Mark Samuels, managing director, NIHR Office for Clinical Research Infrastructure. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:13:17

CDIS 2014: British health care policy in a global landscape

1/30/2014

By Julian Huppert, Lib Dem MP for Cambridge. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: bit.ly/1ghpxeQ Listen to the rest of the podcasts: soundcloud.com/tags/cdis%202014

Duration:00:11:01

CDIS 2014: The Yale-UCL Research and Device Evaluation Program: A trans atlantic academic initiative

1/30/2014

By Alexandra Lansky. This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation Summit, January 2014, run by the Yale-UCL collaborative. View the programme here: http://bit.ly/1ghpxeQ Listen to the rest of the podcasts: https://soundcloud.com/tags/cdis%202014

Duration:00:13:44